407 related articles for article (PubMed ID: 33907323)
1. Interferon lambda in inflammation and autoimmune rheumatic diseases.
Goel RR; Kotenko SV; Kaplan MJ
Nat Rev Rheumatol; 2021 Jun; 17(6):349-362. PubMed ID: 33907323
[TBL] [Abstract][Full Text] [Related]
2. Type III Interferons (Lambda Interferons) in Rheumatic Autoimmune Diseases.
Mora-Arias T; Amezcua-Guerra LM
Arch Immunol Ther Exp (Warsz); 2020 Jan; 68(1):1. PubMed ID: 31915933
[TBL] [Abstract][Full Text] [Related]
3. Type III interferons in innate and adaptive immunity in the respiratory tract.
Piperakis A; Galani IE; Andreakos E
Curr Opin Immunol; 2024 Apr; 87():102430. PubMed ID: 38824869
[TBL] [Abstract][Full Text] [Related]
4. [Interferons and autoimmune diseases].
Niino M; Miyazaki Y
Brain Nerve; 2013 Nov; 65(11):1381-8. PubMed ID: 24200616
[TBL] [Abstract][Full Text] [Related]
5. Lambda interferons in immunity and autoimmunity.
Vlachiotis S; Andreakos E
J Autoimmun; 2019 Nov; 104():102319. PubMed ID: 31481283
[TBL] [Abstract][Full Text] [Related]
6. Interferon Lambda Regulates Cellular and Humoral Immunity in Pristane-Induced Lupus.
Aschman T; Schaffer S; Biniaris Georgallis SI; Triantafyllopoulou A; Staeheli P; Voll RE
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769174
[TBL] [Abstract][Full Text] [Related]
7. Genetic associations in type I interferon related pathways with autoimmunity.
Delgado-Vega AM; Alarcón-Riquelme ME; Kozyrev SV
Arthritis Res Ther; 2010; 12 Suppl 1(Suppl 1):S2. PubMed ID: 20392289
[TBL] [Abstract][Full Text] [Related]
8. The unique regulation and functions of type III interferons in antiviral immunity.
Odendall C; Kagan JC
Curr Opin Virol; 2015 Jun; 12():47-52. PubMed ID: 25771505
[TBL] [Abstract][Full Text] [Related]
9. Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus.
Goel RR; Wang X; O'Neil LJ; Nakabo S; Hasneen K; Gupta S; Wigerblad G; Blanco LP; Kopp JB; Morasso MI; Kotenko SV; Yu ZX; Carmona-Rivera C; Kaplan MJ
Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5409-5419. PubMed ID: 32094169
[TBL] [Abstract][Full Text] [Related]
10. Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.
Chyuan IT; Tzeng HT; Chen JY
Cells; 2019 Aug; 8(9):. PubMed ID: 31450787
[TBL] [Abstract][Full Text] [Related]
11. Shared and Distinct Functions of Type I and Type III Interferons.
Lazear HM; Schoggins JW; Diamond MS
Immunity; 2019 Apr; 50(4):907-923. PubMed ID: 30995506
[TBL] [Abstract][Full Text] [Related]
12. Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control.
Andreakos E; Zanoni I; Galani IE
Curr Opin Immunol; 2019 Feb; 56():67-75. PubMed ID: 30399529
[TBL] [Abstract][Full Text] [Related]
13. Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison.
Galani IE; Rovina N; Lampropoulou V; Triantafyllia V; Manioudaki M; Pavlos E; Koukaki E; Fragkou PC; Panou V; Rapti V; Koltsida O; Mentis A; Koulouris N; Tsiodras S; Koutsoukou A; Andreakos E
Nat Immunol; 2021 Jan; 22(1):32-40. PubMed ID: 33277638
[TBL] [Abstract][Full Text] [Related]
14. Fueling autoimmunity: type I interferon in autoimmune diseases.
Di Domizio J; Cao W
Expert Rev Clin Immunol; 2013 Mar; 9(3):201-10. PubMed ID: 23445195
[TBL] [Abstract][Full Text] [Related]
15. Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2.
Hatton CF; Botting RA; Dueñas ME; Haq IJ; Verdon B; Thompson BJ; Spegarova JS; Gothe F; Stephenson E; Gardner AI; Murphy S; Scott J; Garnett JP; Carrie S; Powell J; Khan CMA; Huang L; Hussain R; Coxhead J; Davey T; Simpson AJ; Haniffa M; Hambleton S; Brodlie M; Ward C; Trost M; Reynolds G; Duncan CJA
Nat Commun; 2021 Dec; 12(1):7092. PubMed ID: 34876592
[TBL] [Abstract][Full Text] [Related]
16. The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases.
Ramaswamy M; Tummala R; Streicher K; Nogueira da Costa A; Brohawn PZ
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681945
[TBL] [Abstract][Full Text] [Related]
17. Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces.
Stanifer ML; Guo C; Doldan P; Boulant S
Front Immunol; 2020; 11():608645. PubMed ID: 33362795
[TBL] [Abstract][Full Text] [Related]
18. Type I interferons in systemic autoimmunity.
Sozzani S; Bosisio D; Scarsi M; Tincani A
Autoimmunity; 2010 Apr; 43(3):196-203. PubMed ID: 20298124
[TBL] [Abstract][Full Text] [Related]
19. Type I interferon signature in systemic lupus erythematosus.
Bezalel S; Guri KM; Elbirt D; Asher I; Sthoeger ZM
Isr Med Assoc J; 2014 Apr; 16(4):246-9. PubMed ID: 24834763
[TBL] [Abstract][Full Text] [Related]
20. Interleukins, interferon and rheumatic disease.
Talal N
Clin Rheum Dis; 1985 Dec; 11(3):633-44. PubMed ID: 2416506
[No Abstract] [Full Text] [Related]
[Next] [New Search]
